RecruitingNCT06953414

Classification and Prediction of Difficult Awake Tracheal Intubation With Flexible Bronchoscopes


Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

313 participants

Start Date

Apr 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopes with preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anesthesia, intensive care and emergency medicine. However, a prospective developed classification for this type of airway management is lacking. Due to the absence of a specifically tailored, validated classification for awake intubation with flexible bronchoscopes, many airway operators and institutions use classification tools that were originally developed for direct laryngoscopy, such as the percentage of glottic opening (POGO) score or Cormack-Lehane classification, although their diagnostic performance for the classification of ATI:FB is unknown. This prospective model development and validation study aims to develop two multivariable prediction models: a diagnostic prediction model to classify difficult ATI:FB after ATI:FB has been performed and a second prognostic prediction model to predict the risk for difficult ATI:FB before ATI:FB is performed. An additional aim is to develop a machine learning algorithm to evaluate ATI:FB.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients with an anticipated difficult airways scheduled for ATI:FB
  • Consent by the patient
  • Minimum 18 years of age

Exclusion Criteria3

  • Patients not scheduled for ATI:FB
  • Pregnant or breastfeeding patients
  • Consent not given by the patient

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Medical Center Hamburg-Eppendorf

Hamburg, Free and Hanseatic City of Hamburg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06953414


Related Trials